painkillers

Vertex picks a horse in race for opioid painkiller replacement
Vertex picks a horse in race for opioid painkiller replacement
Fierce Biotech
Vertex Pharmaceuticals
VX-548
clinical trials
painkillers
non-opioid pain treatments
Flag link:
In highly unusual move, Pacira sues medical journal for libel over its non-opioid painkiller
In highly unusual move, Pacira sues medical journal for libel over its non-opioid painkiller
Endpoints
Pacira
libel
painkillers
medical journals
non-opioid pain treatments
EXPAREL
Flag link:
Trevena preps low-key launch, responsible marketing for long-awaited opioid Olinvyk
Trevena preps low-key launch, responsible marketing for long-awaited opioid Olinvyk
Fierce Pharma
opioids
Trevena
Olinvyk
painkillers
drug launches
Flag link:
Former Indivior CEO pleads guilty in federal Suboxone probe a day after stepping down from post
Former Indivior CEO pleads guilty in federal Suboxone probe a day after stepping down from post
Fierce Pharma
Indivior
Pharma CEOs
Suboxone Film
painkillers
Shaun Thaxter
Flag link:
Tiny Trevena returns to FDA in second bid for controversial opioid painkiller
Tiny Trevena returns to FDA in second bid for controversial opioid painkiller
Endpoints
Trevena
FDA
opioids
painkillers
oliceridine
Flag link:
FDA starts review of Pfizer, Lilly’s non-opioid painkiller
FDA starts review of Pfizer, Lilly’s non-opioid painkiller
Pharmaforum
Pfizer
Eli Lilly
tanezumab
painkillers
FDA
non-opioid pain treatments
Flag link:
Baudax Bio Wins FDA Approval for Anjeso, a Non-Opioid Pain Treatment
Baudax Bio Wins FDA Approval for Anjeso, a Non-Opioid Pain Treatment
BioSpace
Baudax Bio
Anjeso
painkillers
FDA
Flag link:
Vertex drops VX-961 to continue search for perfect pain drug
Vertex drops VX-961 to continue search for perfect pain drug
Fierce Biotech
Vertex Pharmaceuticals
VX-961
painkillers
Flag link:
FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug
FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug
BioSpace
FDA
Durect Corporation
painkillers
non-opioid pain treatments
Posimir
Flag link:
Rough Meeting Ahead Between Nektar Therapeutics and FDA Advisory Committee
Rough Meeting Ahead Between Nektar Therapeutics and FDA Advisory Committee
Motley Fool
Nektar Therapeutics
FDA
oxycodegol
painkillers
Flag link:
Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny
Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny
Fierce Pharma
Daiichi Sankyo
oncology
painkillers
opioids
opioid crisis
Flag link:
IPO take 2: Kindler's Centrexion restarts bid to fund pain trial
IPO take 2: Kindler's Centrexion restarts bid to fund pain trial
Fierce Biotech
Centrexion
IPOs
clinical trials
painkillers
CNTX-4975
osteoarthritis of the knee
Flag link:
Scorpion Venom Could Provide Clue into Non-Opioid Treatments for Chronic Pain
Scorpion Venom Could Provide Clue into Non-Opioid Treatments for Chronic Pain
BioSpace
painkillers
opioids
non-opioid pain treatments
drug development
Flag link:
Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous
Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous
Biopharma Dive
Pfizer
Eli Lilly
painkillers
tanezumab
Regeneron
Teva Pharmaceutical
fasinumab
Flag link:
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
Yahoo/Reuters
Pfizer
Eli Lilly
clinical trials
painkillers
osteoarthritis of the knee
tanezumab
Flag link:
Recro Pharma to Lay Off 50 Following Second FDA Rejection for Non-Opioid Pain Treatment
Recro Pharma to Lay Off 50 Following Second FDA Rejection for Non-Opioid Pain Treatment
BioSpace
Recro Pharma
layoffs
painkillers
non-opioid pain treatments
meloxicam
Flag link:
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
Recro Pharma
Recro Pharma
complete response letter
FDA
meloxicam
painkillers
Flag link:
R&D round-up: Non-opioid painkiller space heats up
R&D round-up: Non-opioid painkiller space heats up
Pharmaforum
painkillers
opioids
non-opioid pain treatments
Merck
Kings College London
Pfizer
Eli Lilly
tanezumab
Xeljanz
Flag link:
Merck gives King's College London, Wellcome Trust up to $340M in deal to develop non-opioid painkillers
Merck gives King's College London, Wellcome Trust up to $340M in deal to develop non-opioid painkillers
Endpoints
Merck
Kings College London
Wellcome Trust
painkillers
opioids
non-opioid pain treatments
Flag link:
New Test Measures Pain Levels Using Biomarkers in the Blood
New Test Measures Pain Levels Using Biomarkers in the Blood
BioSpace
biomarkers
painkillers
diagnostics
opioid crisis
Flag link:

Pages